About us Pricing ContactSubscribe

J

Josep Tabernero

Vall d'Hebron Hospital UniversitariORCID https://orcid.org/0000-0002-2495-8139

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

New England Journal of Medicine20136,561 citations

The consensus molecular subtypes of colorectal cancer

Nature Medicine20155,121 citations

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

Annals of Oncology20163,389 citations

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

Journal of Clinical Oncology20092,274 citations

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

The Lancet Oncology20102,133 citations

Genomic analysis identifies association of <i>Fusobacterium</i> with colorectal carcinoma

Genome Research20111,934 citations

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

Annals of Oncology20121,518 citations

Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of Oncology20201,269 citations

Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials

Annals of Oncology2017819 citations

Targeting the PI3K/Akt/mTOR Pathway - Beyond Rapalogs

Oncotarget2010342 citations

Josep Tabernero · Scinovex